Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemifloxacin-based treatment for Helicobacter pylori infection
IRCT201310221155N17Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gemifloxacin in Helicobacter pylori infection and dyspepsia, sponsored by Guilan University of Medical Sciences. Started Oct 2013; status: completed.
02
Drugs
gemifloxacin
03
Conditions
Helicobacter pylori infectiondyspepsia
Beyond the preview
Go deeper on IRCT201310221155N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201310221155N17.